Skip to main content

Comprehensive Healthcare Solutions

Pioneering precision medicine across cancer prevention, anti-aging and longevity programs, reproductive health and stem cell technologies driving progress through science and innovation.

EPIGENETICS AND GENOMICS OF CARCINOGENESIS

GENOMICS AND THERAPIES OF AGING DRIVER CONDITIONS

PRENATAL AND PRECONCEPTION GENETIC ANALYSIS

STEM CELLS AND EXOSOMES FOR BANKING AND THERAPY

About Bioscience

Bioscience is an international leader in regenerative medicine (with ADSCs and exosomes), cellular biology and genomics. With laboratories, clinics and biobanks in Europe and the Middle East, the Group provides advanced services such as stem cell banking and expansion, non-invasive prenatal testing, longevity healthy program and innovative cancer driver interception protocol. Through its clinical facilities, including the Regenerative Medicine Center in Dubai Healthcare City, Bioscience develops personalized anti-aging and therapeutic programs. In partnership with leading universities, it continues to drive research and innovation for preventive, diagnostic and therapeutic applications.

Discover more

Explore Our Services

Bioscience offers a comprehensive portfolio spanning regenerative medicine, genomics, and personalized healthcare. Our solutions include stem cell banking and expansion, with treatments performed using patient-derived adipose stem cells (ADSCs) or innovative exosome-based therapies. We also provide advanced genomic analyses for monitoring inflammatory states, together with established protocols such as HELIXAFE® for genomic screening and longevity programs powered by proprietary algorithms such as BIOXPACE™ . Discover how innovation and science come together to support health, prevention, and personalized wellbeing.

Discover the areas where science and innovation meet to improve health, wellbeing, and quality of life.

Latest Insights

Stay updated with the most recent news and discoveries from the world of science, genomics and regenerative medicine.

FDA Approves Ryoncil, the First Mesenchymal Stromal Cell Therapy for Children With Steroid-Refractory Acute GvHD

| Cancer prevention | No Comments
The U.S. Food and Drug Administration (FDA) has approved a groundbreaking cell-based therapy, offering renewed hope to children suffering from a severe post-transplant complication: steroid-refractory acute graft-versus-host disease (SR-aGVHD). The…

Breast cancer: risk increased by all kinds of hormonal contraceptives

| Cancer prevention | No Comments
It does not matter if they are combined or progestagen-only: all kinds of hormonal contraceptives increase breast cancer risk. Tests enabling individual risk evaluation can help you protect your health…

Bioscience Institute at the Italian Ministry of Health together with institutions, clinicians, and scientific societies for a new Digital Health

| Latest News | No Comments
With Digital Health, the future is now. This is the message from the institutional meeting “Digital Health: new landscapes for General and Specialist Medicine”. The event highlighted the advantages of…

Webcam Dubai

Webcam San Marino